Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers
Clinical trial NCT03332498 · COMPLETED
Trial details
- NCT number
- NCT03332498
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-24
- Primary completion
- 2019-12-05
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.